BB1 BlinkLab Limited
BlinkLab Limited focuses on the development and commercialization of intellectual property related to smartphone-based neurobehavioural testing. Its smartphone-based application serves as a device for conducting neurobehavioral evaluations and objective sensorimotor biomarkers, which provides scientific support for future regulatory approval and clinical adoption. The company's application also enables remote and rapid testing to aid research on neurodevelopmental and neurodegenerative conditions such as schizophrenia, autism, attention deficit hyperactivity disorder (ADHD), and various forms of dementia. The company was incorporated in 2021 and is based in Perth, Australia.
Returns
| 1 day | 1.5% |
| 1 week | 4.8% |
| 1 month | -10.8% |
| 3 months | -5.7% |
| 6 months | -20.5% |
| 1 year | 23.4% |
| 3 years | — |
Risk
| Volatility (1y ann.) | 75.0% |
| Beta vs ASX 200 | 1.55 |
| Sharpe (1y) | 0.58 |
| VaR 95% (1-day) | -5.6% |
| Max drawdown (1y) | -47.5% |
| Off 1-year high | -39.2% |
Technicals
| RSI(14) | 46 |
| vs 50DMA | -8.1% |
| vs 200DMA | -12.3% |
| Trend | Death cross |
Hover a row's info icon for the exact rule. Bounds and weights are configurable in the Django admin (Scoring configuration).
- Revenue—
- Gross profit—
- Operating income-$8.42M
- Net income-$7.22M
- Diluted EPS—
- Free cash flow-$7.54M
- Net debt-$7.49M